Oncology Institute (TOI) Cash from Investing Activities (2020 - 2026)

Oncology Institute (TOI) has reported Cash from Investing Activities for 7 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$1.0 million, down 415.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.9 million (down 114.7% YoY), and the FY2025 annual result was -$3.1 million, down 106.65% from the prior year.
• Cash from Investing Activities was -$1.0 million for Q1 2026 at Oncology Institute, up from -$1.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $24.9 million in Q2 2023 and troughed at -$87.8 million in Q3 2022.
• Average Cash from Investing Activities over 5 years is -$1.6 million, with a median of -$604000.0 recorded in 2025.
• Year-over-year, Cash from Investing Activities sank 9139.89% in 2022 and soared 1936.43% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$32.6 million in 2022, then jumped by 135.7% to $11.6 million in 2023, then slumped by 115.09% to -$1.8 million in 2024, then surged by 39.6% to -$1.1 million in 2025, then gained by 1.7% to -$1.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$1.0 million in Q1 2026, -$1.1 million in Q4 2025, and -$604000.0 in Q3 2025.